1. Home
  2. PCSA vs CETY Comparison

PCSA vs CETY Comparison

Compare PCSA & CETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

HOLD

Current Price

$2.79

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Logo Clean Energy Technologies Inc.

CETY

Clean Energy Technologies Inc.

HOLD

Current Price

$0.81

Market Cap

9.9M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCSA
CETY
Founded
2011
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Power Generation
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
9.9M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
PCSA
CETY
Price
$2.79
$0.81
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
56.2K
124.8K
Earning Date
05-07-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,000.00
$957,633.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.18
52 Week High
$8.88
$3.05

Technical Indicators

Market Signals
Indicator
PCSA
CETY
Relative Strength Index (RSI) 50.93 46.32
Support Level $1.96 $0.79
Resistance Level $3.26 $0.85
Average True Range (ATR) 0.36 0.06
MACD 0.00 -0.01
Stochastic Oscillator 31.78 13.73

Price Performance

Historical Comparison
PCSA
CETY

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

About CETY Clean Energy Technologies Inc.

Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.

Share on Social Networks: